Company intelligence / Profile preview

Gensenta

Levent, İstanbul, Türkiyegensenta.com.tr ↗
Ownership
Private
Employees
~804
Development stage
Other
01

Overview

Gensenta is a Turkish pharmaceutical manufacturer focused on commercialized generic medicines, hospital injectables, oncology products, antibiotics, corticosteroids, and active pharmaceutical ingredients. The company traces its roots to Mustafa Nevzat Laboratory, was renamed Gensenta in 2020, and has operated as part of the Eczacıbaşı Group since November 2022. Its business is centered on manufacturing and supplying finished dosage forms and APIs rather than developing a disclosed innovative clinical pipeline. Gensenta operates facilities for sterile injectables, lyophilized products, oral solid dosage forms, and API production, and it exports products internationally. The company appears best characterized as an established commercial pharma and manufacturing organization in Türkiye.

Therapeutic areas
ImmunologyCardiovascularNeurologyInfectious DiseasesGastroenterologyOncology
Modalities
Small moleculeBiologic
Industry
Biotech
02

Drug pipeline

2 assets

MP-303

Preclinical

1 more asset in the full pipeline.

03

Partnerships

Beyond the preview

Go deeper on Gensenta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gensenta.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call